These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 29362482)

  • 1. Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.
    Li T; Ma R; Zhang Y; Mo H; Yang X; Hu S; Wang L; Novakovic VA; Chen H; Kou J; Bi Y; Yu B; Fang S; Wang J; Zhou J; Shi J
    Cell Death Dis; 2018 Jan; 9(2):75. PubMed ID: 29362482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PPARγ intensified the effects of arsenic trioxide in acute promyelocytic leukemia through the suppression of PI3K/Akt pathway: Proposing a novel anticancer effect for pioglitazone.
    Esmaeili S; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Salari S; Gharehbaghian A; Hamidpour M; Bashash D
    Int J Biochem Cell Biol; 2020 May; 122():105739. PubMed ID: 32169580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine aggravates the arsenic trioxide (As2O3)-induced apoptosis of acute promyelocytic leukemia NB4 cells via inhibiting lysosomal degradation in vitro.
    Liu DM; Zhang XD; Yang L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6412-6421. PubMed ID: 30338810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
    Ganesan S; Alex AA; Chendamarai E; Balasundaram N; Palani HK; David S; Kulkarni U; Aiyaz M; Mugasimangalam R; Korula A; Abraham A; Srivastava A; Padua RA; Chomienne C; George B; Balasubramanian P; Mathews V
    Leukemia; 2016 Nov; 30(11):2169-2178. PubMed ID: 27560113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PI3K signaling pathway enhances the chemosensitivity of APL cells to ATO: Proposing novel therapeutic potential for BKM120.
    Bashash D; Delshad M; Riyahi N; Safaroghli-Azar A; Pourbagheri-Sigaroodi A; Momeny M
    Eur J Pharmacol; 2018 Dec; 841():10-18. PubMed ID: 30316766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment.
    Zamani-Moghaddam N; Mousavi FS; Esmaeili S; Yousefi AM; Safaroghli-Azar A; Bashash D
    Cancer Treat Res Commun; 2021; 26():100284. PubMed ID: 33387871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
    Ozpolat B; Akar U; Zorrilla-Calancha I; Vivas-Mejia P; Acevedo-Alvarez M; Lopez-Berestein G
    Apoptosis; 2008 Jul; 13(7):915-28. PubMed ID: 18491231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CUDC-101 overcomes arsenic trioxide resistance via caspase-dependent promyelocytic leukemia-retinoic acid receptor alpha degradation in acute promyelocytic leukemia.
    Zhang T; Ma D; Wei D; Lu T; Yu K; Zhang Z; Wang W; Fang Q; Wang J
    Anticancer Drugs; 2020 Feb; 31(2):158-168. PubMed ID: 31584454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of arsenic trioxide by AS3MT favors eradication of acute promyelocytic leukemia: revealing the hidden facts.
    Maimaitiyiming Y; Zhu HH; Yang C; Naranmandura H
    Drug Metab Rev; 2020 Aug; 52(3):425-437. PubMed ID: 32677488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
    Dembitz V; Lalic H; Ostojic A; Vrhovac R; Banfic H; Visnjic D
    Int J Hematol; 2015 Jul; 102(1):12-24. PubMed ID: 25758096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia.
    Guo Z; Meng M; Geng S; Du Z; Zheng Y; Yao J; Li Z; Han G; Lin H; Du G
    J Ethnopharmacol; 2017 Jan; 196():29-38. PubMed ID: 27965050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxiredoxin 3 Has Important Roles on Arsenic Trioxide Induced Apoptosis in Human Acute Promyelocytic Leukemia Cell Line via Hyperoxidation of Mitochondrial Specific Reactive Oxygen Species.
    Mun YC; Ahn JY; Yoo ES; Lee KE; Nam EM; Huh J; Woo HA; Rhee SG; Seong CM
    Mol Cells; 2020 Sep; 43(9):813-820. PubMed ID: 32975211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway.
    Fang S; Wan X; Zou X; Sun S; Hao X; Liang C; Zhang Z; Zhang F; Sun B; Li H; Yu B
    Cell Death Dis; 2021 Jan; 12(1):88. PubMed ID: 33462182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
    Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
    Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role of hematopoietic stem cell transplantation in acute promyelocytic leukemia.
    Nagai S; Takahashi T; Kurokawa M
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):372-8. PubMed ID: 20528759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy: New Insights into Mechanisms of Action and Resistance of Treatment in Acute Promyelocytic leukemia.
    Moosavi MA; Djavaheri-Mergny M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrrolidine Dithiocarbamate Enhances the Cytotoxic Effect of Arsenic Trioxide on Acute Promyelocytic Leukemia Cells.
    Yu S; Ge Z; Chen W; Han J
    Comb Chem High Throughput Screen; 2023; 26(11):2067-2076. PubMed ID: 36694317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
    Dbaibo GS; Kfoury Y; Darwiche N; Panjarian S; Kozhaya L; Nasr R; Abdallah M; Hermine O; El-Sabban M; de Thé H; Bazarbachi A
    Haematologica; 2007 Jun; 92(6):753-62. PubMed ID: 17550847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias.
    Yousefnia S
    Cell Biol Int; 2021 Jun; 45(6):1148-1157. PubMed ID: 33527587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.